U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06835907) titled 'Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study' on Feb. 14.
Brief Summary: The goal of this clinical trial is to determine the efficacy of baclofen for the treatment of alcohol use disorder (AUD) in patients with or without comorbid anxiety symptoms. The main questions it aims to answer are:
* Do we see more abstinent days after the study period in patients with high anxiety symptoms compared to low anxiety symptoms?
* Do we observe additional differences between patients with high- and low anxiety symptoms in: any drinking at the end of treatment (yes/no), number of patients who respond to treatment, anx...